This article has Open Peer Review reports available.
The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
- Xu-Dong Qu†1,
- Cheng-Shi Chen†1,
- Jian-Hua Wang1Email author,
- Zhi-ping Yan1,
- Jie-min Chen1,
- Gao-quan Gong1,
- Qin-xin Liu1,
- Jian-jun Luo1,
- Lin-xiao Liu1,
- Rong Liu1 and
- Sheng Qian1
© Qu et al.; licensee BioMed Central Ltd. 2012
Received: 9 December 2011
Accepted: 21 June 2012
Published: 21 June 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|9 Dec 2011||Submitted||Original manuscript|
|30 Dec 2011||Author responded||Author comments - xudong qu|
|Resubmission - Version 2|
|30 Dec 2011||Submitted||Manuscript version 2|
|9 Feb 2012||Reviewed||Reviewer Report - Hongming Pan|
|14 Mar 2012||Reviewed||Reviewer Report - Hee Chul Park|
|15 Mar 2012||Reviewed||Reviewer Report - Jia-Hong Dong|
|16 Apr 2012||Author responded||Author comments - xudong qu|
|Resubmission - Version 3|
|16 Apr 2012||Submitted||Manuscript version 3|
|29 Apr 2012||Reviewed||Reviewer Report - Hongming Pan|
|1 May 2012||Reviewed||Reviewer Report - Jia-Hong Dong|
|8 May 2012||Reviewed||Reviewer Report - Hee Chul Park|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|21 Jun 2012||Editorially accepted|
|21 Jun 2012||Article published||10.1186/1471-2407-12-263|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.